Search Results 641-650 of 21524 for Inhibition

  1. Deborah Msekela: Sleep-Related Epilepsy - Student Research - Mayo Clinic College of Medicine & Science

    The mutations affect the way neurons communicate with each other, tipping the balance between nerve cell excitation and inhibition. This imbalance produces ...

  2. Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women - Mayo Clinic

    The purpose of the study is to determine whether treatment with a PI3K inhibitor plus letrozole leads to an increase in pathologic clinical response and ...

  3. Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

    We are specifically exploring PP4 inhibition as a strategy to sensitize tumors to immune checkpoint blockade, enabling more effective combination ...

  4. Dermatology - Clinical trials

    ... inhibition. We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive ...

  5. CAR-T Cell Therapy Program - Clinical trials

    ... inhibition. We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive ...

  6. A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

    ... inhibitor quemliclustat, and chemotherapy in the second-line (2L) or greater setting in participants with locally advanced unresectable or metastatic ...

  7. Rosuvastatin (oral route) - Side effects & dosage - Mayo Clinic

    Rosuvastatin belongs to a group of medicines called HMG-CoA reductase inhibitors, or statins. It works by blocking an enzyme that is needed by the body to ...

  8. A Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors that have NTRK1/2/3, ROS1, or ALK Gene Rearrangements - Mayo Clinic

    Prior anticancer therapy is allowed (excluding approved or investigational Trk, ROS1, or ALK (non-NSCLC patients only) inhibitors in patients who have tumors ...

  9. Publications - Xia Zhou, M.B., Ph.D. - Mayo Clinic

    Li LX, Zhou JX, Li X. Authors' Reply: Deciphering the Cell-Specific Specificity of the a-Klotho-Cellular Inhibitor ... Sirtuin 1 inhibition delays cyst formation ...

  10. Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - Mayo Clinic

    Prior receipt of a selective FGFR inhibitor. History of and/or current ... Use of any potent CYP3A4 inhibitors or inducers within 14 days or 5 half ...